UCFICN Healthy Food Tech Group Corp.Financial Services · Shell Companiesas of 2026-08-20
Horizon

Issued 2026-08-20 at $5.51 · now $5.51 (2026-08-10, +0.0% since)

Based on its own history, a month from the 2026-08-20 close, UCFI has typically landed between $3.63 and $6.26 — a range of −34.2% to +13.7% from the issuance price $5.51.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

545 overlapping 1 month windows · 2024-02-162026-07-10 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,375 obs).

The cone is anchored at the 2026-08-20 issuance close ($5.51) — the price the forecast resolves against on 2026-09-18, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where UCFI has typically landed a month from the 2026-08-20 close of $5.51 — the range is history, not a prediction.

$3.63worst · -34.2%$6.26best · +13.7%
  • now $5.51 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $5.52 (+0.1%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $5.5$5.53
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $3.63$6.26
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 545 windows spanning 2024-02-16 to 2026-08-10. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2025-09-03−51.1%−51.1%+0.0%
2025-09-15−49.4%−49.4%+0.0%
2025-09-02−47.6%−47.6%+7.2%
3 best
2025-07-07+87.4%+0.0%+105.4%
2025-08-14+55.4%+0.0%+78.6%
2025-08-15+50.1%+0.0%+78.6%

545 overlapping windows · 2024-02-162026-08-10 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~3 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
50%
+0.5%
n=2
Feb
50%
+0.3%
n=2
Mar
33%
+0.1%
n=3
Apr
100%
+0.5%
n=2
May
100%
+0.3%
n=2
Jun
0%
−0.8%
n=3
Jul
67%
+2.1%
n=3
Aug
33%
−3.4%
n=3
Sep
100%
+3.2%
n=2
Oct
50%
−23.1%
n=2
Nov
50%
+0.2%
n=2
Dec
0%
+0.0%
n=2

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-082025-07$13$6↑ buys↓ sales
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

6 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2025-09-30Bengochea Jose AntoniootherAward / grant500,000580,000Form 4
2025-09-30Caragol William JdirectorAward / grant500,000580,000Form 4
2025-09-30Bengochea Jose AntoniootherAward / grant2,533,5002,533,500Form 4
2025-09-30Bengochea Jose AntoniootherAward / grant1,932,0001,932,000Form 4
2025-09-30Caragol William JdirectorAward / grant80,00080,000Form 4
2025-09-30Jiang ZhenjundirectorAward / grant47,689,34947,689,349Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.